Total Liabilities Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual total liabilities in 2023 was 207.92 Billion DKK , up 31.79% from previous year.
Novo Nordisk A/S's latest quarterly total liabilities in 2024 Q1 was 200.01 Billion DKK , down -3.81% from previous quarter.
Novo Nordisk A/S reported annual total liabilities of 157.77 Billion DKK in 2022, up 27.48% from previous year.
Novo Nordisk A/S reported annual total liabilities of 123.76 Billion DKK in 2021, up 51.67% from previous year.
Novo Nordisk A/S reported quarterly total liabilities of 256.86 Billion DKK for 2024 Q2, up 28.42% from previous quarter.
Novo Nordisk A/S reported quarterly total liabilities of 170.15 Billion DKK for 2023 Q1, up 7.85% from previous quarter.

Annual Total Liabilities Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Total Liabilities of Novo Nordisk A/S (2023 - 1989)

Year	Total Liabilities	Total Liabilities Growth
2023	207.92 Billion DKK	31.79%
2022	157.77 Billion DKK	27.48%
2021	123.76 Billion DKK	51.67%
2020	81.59 Billion DKK	19.96%
2019	68.01 Billion DKK	15.42%
2018	58.93 Billion DKK	12.16%
2017	52.54 Billion DKK	0.52%
2016	52.27 Billion DKK	16.6%
2015	44.83 Billion DKK	21.93%
2014	36.76 Billion DKK	32.41%
2013	27.76 Billion DKK	10.91%
2012	25.03 Billion DKK	-8.12%
2011	27.25 Billion DKK	11.51%
2010	24.43 Billion DKK	28.56%
2009	19 Billion DKK	7.58%
2008	17.66 Billion DKK	13.46%
2007	15.57 Billion DKK	6.9%
2006	14.56 Billion DKK	1.84%
2005	14.3 Billion DKK	29.93%
2004	11 Billion DKK	19.73%
2003	9.19 Billion DKK	7.45%
2002	8.55 Billion DKK	-2.17%
2001	8.74 Billion DKK	-1.23%
2000	8.85 Billion DKK	-28.66%
1999	12.41 Billion DKK	33.41%
1998	9.3 Billion DKK	23.86%
1997	7.51 Billion DKK	49.54%
1996	5.02 Billion DKK	-12.25%
1995	5.72 Billion DKK	-28.41%
1994	7.99 Billion DKK	9.76%
1993	7.28 Billion DKK	17.14%
1992	6.21 Billion DKK	7.79%
1991	5.77 Billion DKK	5.47%
1990	5.47 Billion DKK	1.3%
1989	5.4 Billion DKK	45.96%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	200.01 Billion DKK	-3.81%
2024 Q2	256.86 Billion DKK	28.42%
2023 Q1	170.15 Billion DKK	7.85%
2023 Q2	190.28 Billion DKK	11.83%
2023 Q4	207.92 Billion DKK	0.39%
2023 Q3	207.11 Billion DKK	8.84%
2023 FY	207.92 Billion DKK	31.79%
2022 Q1	130.58 Billion DKK	5.51%
2022 Q4	157.77 Billion DKK	-5.05%
2022 Q3	166.15 Billion DKK	15.01%
2022 Q2	144.47 Billion DKK	10.64%
2022 FY	157.77 Billion DKK	27.48%
2021 Q3	107.97 Billion DKK	16.68%
2021 Q4	123.76 Billion DKK	14.62%
2021 FY	123.76 Billion DKK	51.67%
2021 Q2	92.53 Billion DKK	11.64%
2021 Q1	82.89 Billion DKK	1.59%
2020 FY	81.59 Billion DKK	19.96%
2020 Q4	81.59 Billion DKK	1.52%
2020 Q1	71.85 Billion DKK	5.64%
2020 Q2	76.06 Billion DKK	5.86%
2020 Q3	80.37 Billion DKK	5.66%
2019 FY	68.01 Billion DKK	15.42%
2019 Q3	71.95 Billion DKK	11.0%
2019 Q4	68.01 Billion DKK	-5.47%
2019 Q2	64.82 Billion DKK	3.2%
2019 Q1	62.81 Billion DKK	6.59%
2018 Q3	54.38 Billion DKK	0.4%
2018 Q2	54.16 Billion DKK	9.83%
2018 Q4	58.93 Billion DKK	8.36%
2018 Q1	49.32 Billion DKK	-6.13%
2018 FY	58.93 Billion DKK	12.16%
2017 FY	52.54 Billion DKK	0.52%
2017 Q4	52.54 Billion DKK	3.13%
2017 Q3	50.94 Billion DKK	3.15%
2017 Q2	49.38 Billion DKK	-8.39%
2017 Q1	53.91 Billion DKK	3.14%
2016 FY	52.27 Billion DKK	16.6%
2016 Q4	52.27 Billion DKK	13.6%
2016 Q2	45.68 Billion DKK	1.33%
2016 Q3	46.01 Billion DKK	0.72%
2016 Q1	45.08 Billion DKK	0.57%
2015 Q1	45.34 Billion DKK	23.34%
2015 FY	44.83 Billion DKK	21.93%
2015 Q4	44.83 Billion DKK	6.52%
2015 Q3	42.08 Billion DKK	-0.27%
2015 Q2	42.2 Billion DKK	-6.94%
2014 Q4	36.76 Billion DKK	10.36%
2014 Q2	27.02 Billion DKK	-8.89%
2014 Q1	29.65 Billion DKK	6.81%
2014 FY	36.76 Billion DKK	32.41%
2014 Q3	33.31 Billion DKK	23.3%
2013 Q2	28.93 Billion DKK	1.0%
2013 Q3	29 Billion DKK	0.27%
2013 Q4	27.76 Billion DKK	-4.28%
2013 FY	27.76 Billion DKK	10.91%
2013 Q1	28.64 Billion DKK	14.41%
2012 Q3	30.96 Billion DKK	4.44%
2012 Q1	28.85 Billion DKK	5.88%
2012 Q2	29.64 Billion DKK	2.75%
2012 Q4	25.03 Billion DKK	-19.13%
2012 FY	25.03 Billion DKK	-8.12%
2011 FY	27.25 Billion DKK	11.51%
2011 Q4	27.25 Billion DKK	2.5%
2011 Q1	24.23 Billion DKK	-0.83%
2011 Q3	26.58 Billion DKK	8.24%
2011 Q2	24.56 Billion DKK	1.36%
2010 Q3	22.89 Billion DKK	-2.2%
2010 Q4	24.43 Billion DKK	6.72%
2010 Q2	23.41 Billion DKK	10.24%
2010 Q1	21.23 Billion DKK	11.74%
2010 FY	24.43 Billion DKK	28.56%
2009 Q1	18.86 Billion DKK	6.74%
2009 FY	19 Billion DKK	7.58%
2009 Q4	19 Billion DKK	7.3%
2009 Q3	17.71 Billion DKK	3.23%
2009 Q2	17.16 Billion DKK	-9.01%
2008 Q3	16.8 Billion DKK	8.82%
2008 Q4	17.66 Billion DKK	5.16%
2008 Q1	16.26 Billion DKK	4.45%
2008 FY	17.66 Billion DKK	13.46%
2008 Q2	15.44 Billion DKK	-5.07%
2007 Q4	15.57 Billion DKK	2.07%
2007 Q3	15.25 Billion DKK	2.84%
2007 Q1	15.06 Billion DKK	3.44%
2007 Q2	14.83 Billion DKK	-1.55%
2007 FY	15.57 Billion DKK	6.9%
2006 FY	14.56 Billion DKK	1.84%
2006 Q4	14.56 Billion DKK	-5.8%
2006 Q3	15.46 Billion DKK	8.57%
2006 Q2	14.24 Billion DKK	-0.14%
2006 Q1	14.26 Billion DKK	-0.28%
2005 FY	14.3 Billion DKK	29.93%
2005 Q4	14.3 Billion DKK	5.29%
2005 Q3	13.58 Billion DKK	12.39%
2005 Q2	12.08 Billion DKK	12.17%
2005 Q1	10.77 Billion DKK	-2.11%
2004 FY	11 Billion DKK	19.73%
2004 Q1	9.72 Billion DKK	5.8%
2004 Q3	9.91 Billion DKK	6.43%
2004 Q2	9.31 Billion DKK	-4.22%
2004 Q4	11 Billion DKK	11.02%
2003 Q4	9.19 Billion DKK	0.0%
2003 FY	9.19 Billion DKK	7.45%
2002 Q4	8.55 Billion DKK	0.0%
2002 FY	8.55 Billion DKK	-2.17%
2001 Q4	8.74 Billion DKK	0.0%
2001 FY	8.74 Billion DKK	-1.23%
2000 FY	8.85 Billion DKK	-28.66%
2000 Q4	8.85 Billion DKK	0.0%
1999 Q4	12.41 Billion DKK	0.0%
1999 FY	12.41 Billion DKK	33.41%
1998 FY	9.3 Billion DKK	23.86%
1998 Q4	9.3 Billion DKK	0.0%
1997 FY	7.51 Billion DKK	49.54%
1997 Q4	7.51 Billion DKK	0.0%
1996 Q4	5.02 Billion DKK	0.0%
1996 FY	5.02 Billion DKK	-12.25%
1995 FY	5.72 Billion DKK	-28.41%
1995 Q4	5.72 Billion DKK	0.0%
1994 Q4	7.99 Billion DKK	0.0%
1994 FY	7.99 Billion DKK	9.76%
1993 FY	7.28 Billion DKK	17.14%
1993 Q4	7.28 Billion DKK	0.0%
1992 FY	6.21 Billion DKK	7.79%
1992 Q4	6.21 Billion DKK	0.0%
1991 FY	5.77 Billion DKK	5.47%
1991 Q4	5.77 Billion DKK	0.0%
1990 Q4	5.47 Billion DKK	0.0%
1990 FY	5.47 Billion DKK	1.3%
1989 FY	5.4 Billion DKK	45.96%
1989 Q4	5.4 Billion DKK	0.0%

Peer Total Liabilities Comparison of Novo Nordisk A/S

Name	Total Liabilities	Total Liabilities Difference
ADC Therapeutics SA	503.03 Million USD	-41234.431%
Alto Neuroscience, Inc.	158.3 Million USD	-131248.705%
Annovis Bio, Inc.	17.95 Million USD	-1157668.954%
Biohaven Pharmaceutical Holding Company Ltd.	85.23 Million USD	-243837.492%
Ginkgo Bioworks Holdings, Inc.	568.19 Million USD	-36494.273%
Nuvation Bio Inc.	16.36 Million USD	-1270679.933%
Nuvation Bio Inc.	16.36 Million USD	-1270679.933%
Arcus Biosciences, Inc.	633 Million USD	-32747.551%
Theriva Biologics, Inc.	20.51 Million USD	-1013476.094%
Zymeworks Inc.	116.07 Million USD	-179031.416%

Global Stocks Search

Novo Nordisk A/S (NVO)

Total Liabilities Summary of Novo Nordisk A/S

Annual Total Liabilities Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Total Liabilities of Novo Nordisk A/S (2023 - 1989)

Peer Total Liabilities Comparison of Novo Nordisk A/S